What is the role of oral or subcutaneous immunotherapy in the management of bronchial asthma and allergic rhinitis, and how does it compare to inhaled steroid therapy?

Fuente: Zenodo
Enregistré dans:
Détails bibliographiques
Auteur principal: Tripdatabase
Format: Recurso digital
Publié: Zenodo 2025
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1866901729575960576
author Tripdatabase
author_facet Tripdatabase
contents Oral and subcutaneous immunotherapy may offer long-term benefits in allergic rhinitis and asthma by modifying disease mechanisms, complementing inhaled steroids, which are central for immediate symptom control.
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_18087591
institution Zenodo
language
publishDate 2025
publisher Zenodo
record_format zenodo
spellingShingle What is the role of oral or subcutaneous immunotherapy in the management of bronchial asthma and allergic rhinitis, and how does it compare to inhaled steroid therapy?
Tripdatabase
role
oral
subcutaneous
immunotherapy
management
bronchial
asthma
allergic
rhinitis
compare
inhaled
steroid
therapy
Oral and subcutaneous immunotherapy may offer long-term benefits in allergic rhinitis and asthma by modifying disease mechanisms, complementing inhaled steroids, which are central for immediate symptom control.
title What is the role of oral or subcutaneous immunotherapy in the management of bronchial asthma and allergic rhinitis, and how does it compare to inhaled steroid therapy?
topic role
oral
subcutaneous
immunotherapy
management
bronchial
asthma
allergic
rhinitis
compare
inhaled
steroid
therapy
url https://doi.org/10.5281/zenodo.18087591